GlassScriptPhysician profile
Christopher G Stevens
NPI 1760685226
$1,474.46
in general payments reported to CMS, 2019-2025
8 companies · $811 in 2025
The $811 reported for 2025 was more than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $153 · 2021: $154 · 2022: $34.15 · 2023: $165 · 2025: $811.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $711 · Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $710.62 |
| Food and Beverage | $266.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $735.12 | 2019-2025 | Comprehensive |
| Stryker Corporation | $293.42 | 2019-2023 | Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid, Tornier Perform Anatomic Augmented Glenoid |
| Pacira Therapeutics, INC. | $147.73 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $140.24 | 2019-2025 | Exparel |
| Depuy Synthes Sales INC. | $60.67 | 2022-2023 | Inhance |
| Kowa Pharmaceuticals America, INC. | $43.99 | 2023 | Seglentis |
| Orthofix Medical, INC. | $39.96 | 2020 | |
| Smith+Nephew, INC. | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.